Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > National Dendrimer and Nano Center Attracts Emerging Bio Lab

CMU National Dendrimer and Nanotechnology Center Attracts Emerging Biotechnology Laboratory

Posted on January 06, 2006

A company developing biotechnologies for coatings and artificial cells that may treat many health conditions is locating a laboratory at Central Michigan University.

Initially, two researchers from Connecticut-based Artificial Cell Technologies Inc. will be located in CMU's Dow Science Complex. One ACT staff person has been at CMU since last summer.

In the future, ACT will join Dendritic NanoTechnologies Inc. and MultiGEN Diagnostics Inc. in relocating to a $5 million CMU wet lab facility that is supported by a $2.15 million U.S. Department of Commerce grant, $250,000 in Michigan Economic Development Corp. funding and $2.6 million from CMU.

The company is commercializing a new nanotechnology involving designed polypeptides that may lead to treatments for many health conditions and opportunities for research for CMU faculty and students.

Using technology originally developed at Louisiana Tech University, ACT designs, characterizes and produces complex, multilayer, nano-assembled polypeptide films, coatings and microcapsules. Peptides are natural or synthetic compounds containing two or more amino acids. Polypeptides are small proteins typically containing between 10 and 100 molecules of amino acids.

Among ACT's current research and development priorities are enantioselective filter membranes for pharmaceutical research and manufacturing, coatings for cell and tissue culture, and the encapsulation of hemoglobin to make artificial red blood cells. A safe, universally transfusible artificial red blood cell with a long life span in the body would transform human health, potentially eliminating blood supply shortages while also representing a new treatment modality for chronic conditions such as congestive heart disease, microvasculature disease and long-lasting anemias such as those caused by malaria.

ACT's technology also appears well suited to development of microcapsules for systemic or targeted drug delivery with tunable timed-release and other useful medical properties, multiantigen artificial virus vaccines, biocompatible coatings for medical devices and instruments, and antimicrobial coatings for food, food packaging or clothing.

ACT Chief Scientific Officer Don Haynie said that from the time of his first visit to CMU, he has been impressed with the capabilities of CMU's faculty and students, as well as the advanced equipment and facilities. The potential for synergistic relationships with other young technology firms at CMU's National Dendrimer and Nanotechnology Center, including Dendritic Nanotechnologies and Bio-ID Diagnostic, also appeals to Haynie.

"We are excited about the opportunity to be involved in bringing new educational opportunities to CMU while also leveraging the many scientific assets available within the central Michigan community to help ACT develop and commercialize our valuable products," said Haynie.

CMU students and faculty will have the opportunity to collaborate on projects and learn new skills through hands-on research experiences, including polypeptide synthesis and purification and the design and assembly of polypeptide nanostructures.

ACT Chief Executive Officer Tom Malone said, "The potential for achieving world-leading therapeutic and industrial advancements is greatly advanced by CMU's willingness to invest time, money and energy in fostering university-private company partnerships."

Malone also credited the support and vision of top officers at the university, valuable business services from the CMU Research Corp., and lower operating costs associated with research and development activities, when compared to the East Coast.

####
CMURC Contact:
Brent Case
(989) 774-1021
brent.case@cmich.edu

ACT Contact:
Thomas Malone
(203) 402-7209

Copyright Central Michigan University

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Possible Futures

Solar-to-fuel system recycles CO2 to make ethanol and ethylene: Berkeley Lab advance is first demonstration of efficient, light-powered production of fuel via artificial photosynthesis September 19th, 2017

A new approach to ultrafast light pulses: Unusual fluorescent materials could be used for rapid light-based communications systems September 19th, 2017

Hydrogen power moves a step closer: Physicists are developing methods of creating renewable fuel from water using quantum technology September 15th, 2017

New insights into nanocrystal growth in liquid: Understanding process that creates complex crystals important for energy applications September 14th, 2017

Investments/IPO's/Splits

Arrowhead Hosts Investor & Analyst R&D Day to Introduce TRiM(TM) Platform and Lead RNAi-based Drug Candidates September 14th, 2017

Nanometrics Announces Upcoming Investor Events August 3rd, 2017

Nanometrics to Participate in the 9th Annual CEO Investor Summit 2017: Accredited investor and publishing research analyst event held concurrently with SEMICON West and Intersolar 2017 in San Francisco June 27th, 2017

180 Degree Capital Corp. Announces the Start of Kevin Rendino as Chairman and Chief Executive Officer and Completion of its Transition to a Registered Closed-End Fund March 31st, 2017

Nanomedicine

Do titanium dioxide particles from orthopedic implants disrupt bone repair? September 16th, 2017

Arrowhead Hosts Investor & Analyst R&D Day to Introduce TRiM(TM) Platform and Lead RNAi-based Drug Candidates September 14th, 2017

Graphene based terahertz absorbers: Printable graphene inks enable ultrafast lasers in the terahertz range September 13th, 2017

Applications for the nanomedTAB are open until September 18th, 2017 September 13th, 2017

Materials/Metamaterials

New quantum phenomena in graphene superlattices September 18th, 2017

New insights into nanocrystal growth in liquid: Understanding process that creates complex crystals important for energy applications September 14th, 2017

Corrosion in real time: UCSB researchers get a nanoscale glimpse of crevice and pitting corrosion as it happens September 14th, 2017

Graphene based terahertz absorbers: Printable graphene inks enable ultrafast lasers in the terahertz range September 13th, 2017

Announcements

Solar-to-fuel system recycles CO2 to make ethanol and ethylene: Berkeley Lab advance is first demonstration of efficient, light-powered production of fuel via artificial photosynthesis September 19th, 2017

A new approach to ultrafast light pulses: Unusual fluorescent materials could be used for rapid light-based communications systems September 19th, 2017

New quantum phenomena in graphene superlattices September 18th, 2017

Do titanium dioxide particles from orthopedic implants disrupt bone repair? September 16th, 2017

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project